Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Rexahn
chemotherapy
Amgen
Bristol-Myers Squibb
Merck
Novartis
Teva
RX-3117
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Cancer immunotherapies turn a corner in race to megablockbuster market
Fierce Biotech
Wed, 10/2/13 - 10:54 am
cancer immunotherapy
Merck
MK-3475
nivolumab
Bristol-Myers Squibb
Roche
MPDL3280A
PDL-1
3 Cancer Investing Opportunities
Seeking Alpha
Tue, 10/1/13 - 10:10 am
Merck
cancer
AstraZeneca
Bristol-Myers Squibb
MK-1775
ovarian cancer
MK-3475
melanoma
Yervoy
Yervoy Battles Melanoma, but Can It Become a Blockbuster?
Motley Fool
Sun, 09/29/13 - 01:57 pm
Yervoy
melanoma
Bristol-Myers Squibb
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Sat, 09/28/13 - 01:09 pm
biotech
Perrigo
Bristol-Myers Squibb
Elan
Clovis Oncology
IPOs
Stemline
Amgen
Biogen Idec
ONYX Pharmaceuticals
Bristol-Myers: Interesting Investing Opportunity With Onglyza
Seeking Alpha
Sat, 09/28/13 - 12:15 pm
type 2 diabetes
Onglyza
diabetes
Bristol-Myers Squibb
AstraZeneca
Bristol’s Yervoy Adds Up to 10 Years of Life for Cancer Patients
Bloomberg
Sat, 09/28/13 - 12:13 pm
Yervoy
Bristol-Myers Squibb
These Drug Makers Are Still Standing Strong
Seeking Alpha
Fri, 09/27/13 - 11:45 am
Bristol-Myers Squibb
Pfizer
JNJ
Eliquis
Xarelto
bloodthinners
Lilly Bets Quality Will Pay Off in U.S. Diabetes Battle
Bloomberg
Wed, 09/25/13 - 08:41 am
Eli Lilly
diabetes
Novo Nordisk
Bristol-Myers Squibb
Merck
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Biogen Idec
AbbVie
Amgen
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Cephalon
Bristol-Myers, AstraZeneca diabetes drug delivers improvement for patients in late-stage study
Yahoo/AP
Tue, 09/24/13 - 10:13 am
Bristol-Myers Squibb
diabetes
AstraZeneca
Dapagliflozin
The Pharmaceutical Industry's 10 Biggest R&D Budgets
Motley Fool
Mon, 09/23/13 - 12:02 pm
R&D
Roche
Pfizer
Merck
JNJ
Novartis
Sanofi
GSK
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
Groundbreaking Diabetes Drug Headlines Approval Bonanza
Motley Fool
Sun, 09/22/13 - 11:25 am
diabetes
type 2 diabetes
type 1 diabetes
JNJ
inokana
Forxiga
AstraZeneca
Bristol-Myers Squibb
5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer
Motley Fool
Sun, 09/22/13 - 11:23 am
LDK378
Novartis
bavituximab
Peregrine Pharmaceuticals
nivolumab
Bristol-Myers Squibb
lambrolizumab
Merck
lung cancer
CO-1686
Clovis Oncology
AstraZeneca, Bristol Recall Bydureon Diabetes Drug For Under-Filled Vials
WSJ Online
Fri, 09/20/13 - 10:20 am
AstraZeneca
Bristol-Myers Squibb
Bydureon
diabetes
recalls
3 Companies Racing to Transform Hepatitis-C Treatment
Motley Fool
Thu, 09/19/13 - 02:58 am
hepatitis C
Gilead
sofosbuvir
AbbVie
Bristol-Myers Squibb
daclatasvir
asunaprevir
BMS-791325
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Mon, 09/16/13 - 11:48 am
Celgene
FDA
Bristol-Myers Squibb
AbbVie
JNJ
Eli Lilly
Revlimid
Abraxane
Bristol-Myers Squibb: Another Brick In The Wall
Seeking Alpha
Mon, 09/16/13 - 10:07 am
Bristol-Myers Squibb
Yervoy
prostate cancer
Pages
« first
‹ previous
…
54
55
56
57
58
59
60
61
62
…
next ›
last »